These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19597298)

  • 1. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction.
    Ichimoto E; Jo K; Kobayashi Y; Inoue T; Nakamura Y; Kuroda N; Miyazaki A; Komuro I
    Circ J; 2009 Sep; 73(9):1669-73. PubMed ID: 19597298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C in a high-risk combination.
    Iwanaga Y; Miyazaki S
    Circ J; 2009 Sep; 73(9):1593-4. PubMed ID: 19706985
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
    Dupont M; Wu Y; Hazen SL; Tang WH
    Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Cystatin C Level in ST-Elevation Myocardial Infarction Predisposes the Prognosis of Angioplasty.
    Shen G; Zhu H; Ding H; Sun C; Zhou K; Fan Y; Li T; Men M; Chen Y; Lu Q; Ma A
    Am J Med Sci; 2018 Jun; 355(6):530-536. PubMed ID: 29891036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction.
    Silva D; Cortez-Dias N; Jorge C; Marques JS; Carrilho-Ferreira P; Magalhães A; Martins SR; Gonçalves S; da Silva PC; Fiúza M; Diogo AN; Pinto FJ
    Am J Cardiol; 2012 May; 109(10):1431-8. PubMed ID: 22356795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
    Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
    Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cardiac time intervals by tissue Doppler imaging M-mode in patients with acute ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Biering-Sørensen T; Mogelvang R; Søgaard P; Pedersen SH; Galatius S; Jørgensen PG; Jensen JS
    Circ Cardiovasc Imaging; 2013 May; 6(3):457-65. PubMed ID: 23536267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of direct versus conventional stenting in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Isik T; Ayhan E; Uyarel H; Ergelen M; Cicek G; Osmonov D; Turkkan C; Turer A; Ghannadian B; Eren M
    Coron Artery Dis; 2012 Aug; 23(5):348-53. PubMed ID: 22566098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Karabay CY; Kurt M; Akgün T; Bulut M; Pala S; Kirma C
    Coron Artery Dis; 2013 Mar; 24(2):88-94. PubMed ID: 23249632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
    Droppa M; Desch S; Blase P; Eitel I; Fuernau G; Schuler G; Adams V; Thiele H
    Clin Res Cardiol; 2011 Nov; 100(11):1037-43. PubMed ID: 21710343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.
    Ristiniemi N; Lund J; Tertti R; Christensson A; Ilva T; Porela P; Pulkki K; Pettersson K
    Clin Biochem; 2012 May; 45(7-8):535-40. PubMed ID: 22394460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
    Akerblom Å; Wallentin L; Siegbahn A; Becker RC; Budaj A; Buck K; Giannitsis E; Horrow J; Husted S; Katus HA; Steg PG; Storey RF; Åsenblad N; James SK
    Clin Chem; 2012 Jan; 58(1):190-9. PubMed ID: 22126936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction.
    Barbarash OL; Bykova IS; Kashtalap VV; Zykov MV; Hryachkova ON; Kalaeva VV; Shafranskaya KS; Karetnikova VN; Kutikhin AG
    BMC Cardiovasc Disord; 2017 Mar; 17(1):81. PubMed ID: 28298190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.